Director, Global Business Ethics – Third Party and Anti-Corruption Program MW (based Paris or London)

London - UK

Monthly Salary: Not Disclosed

Posted on: Yesterday

Vacancies: 1 Vacancy

Job Summary

Title:

Director Global Business Ethics Third Party and Anti-Corruption Program M/W (based Paris or London)

Company:

Ipsen Biopharm Ltd

About Ipsen:

Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neuroscience. Supported by nearly 100 years of development experience with global hubs in the U.S. France and the U.K we tackle areas of high unmet medical need through research and innovation.

Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration excellence and impact. At Ipsen every individual is empowered to be their true selves grow and thrive alongside the companys success. Join us on our journey towards sustainable growth creating real impact on patients and society!

For more information visit us at follow our latest news on LinkedIn and Instagram.

Job Description:

The Global Business Ethics Director leads the companys global Anti-Corruption and Business Ethics Third Party Programs ensuring compliance with international laws regulations and industry best practices while promoting a strong culture of integrity across all functions and geographies.

As a strategic partner to senior leadership the role provides governance oversight and expert guidance on ethics and compliance matters with a particular focus on third-party risk management program governance training monitoring and reporting.

The position is responsible for defining and driving program strategy overseeing global third-party due diligence processes and systems and continuously enhancing best-in-class frameworks aligned with evolving regulatory and business expectations. The Global Business Ethics Director serves as the primary point of contact for senior management and governance bodies leads cross-functional committees manages key external vendors and supports external program certifications.

The role also ensures the effective communication and deployment of Anti-Corruption and Third Party standards worldwide supports the development of training for employees and third parties and oversees program monitoring analytics and reporting. Regular insights and risk assessments are provided to senior management to enable informed decision-making and continuous improvement.

The ideal candidate brings a minimum of 10 years of Ethics and Compliance experience within the pharmaceutical or medical device industry strong business acumen and the ability to influence at all organizational levels. Excellent communication skills sound judgment and a proven ability to manage complex ethical and compliance risks in a global cross-functional environment are essential. Fluency in English is required; French is a plus.

This role can be based either in Paris or London.

We are committed to creating a workplace where everyone feels heard valued and supported; where we embrace The Real Us. The value we place on different perspectives and experiences drives our commitment to inclusion and equal opportunities. When we include diverse ways of thinking we make more thoughtful decisions and discover more innovative solutions. Together we strive to better understand the communities we serve. This means we also want to help you perform at your best when applying for a role with us. If you require any adjustments or support during the application process please let the recruitment team know. This information will be handled with care and will not affect the outcome of your application.

Required Experience:

Director

Title:Director Global Business Ethics Third Party and Anti-Corruption Program M/W (based Paris or London)Company:Ipsen Biopharm LtdAbout Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology Rare Disease and Neurosc...